20 research outputs found

    NK/T ์„ธํฌ ๋ฆผํ”„์ข…์—์„œ DNA ๊ณผ๋ฉ”ํ‹ธํ™”์— ์˜ํ•ด ๋ฐœํ˜„์ด ์–ต์ œ๋˜๋Š” microRNA์˜ ์Šคํฌ๋ฆฌ๋‹ ๋ฐ ์กฐ์ ˆ๊ธฐ์ „ ๋ถ„์„

    No full text
    NK/T ์„ธํฌ ๋ฆผํ”„์ข…(NK/T cell lymphoma, NKTL)์€ ์—ก์Šคํƒ€์ธ ๋ฐ” ๋ฐ”์ด๋Ÿฌ์Šค์™€ ๋†’์€ ๊ด€๋ จ์„ฑ์„ ๋ณด์ด๋Š” ์•…์„ฑ ์ข…์–‘์œผ๋กœ ์ฃผ๋กœ ๋ฆผํ”„์ ˆ์™ธ ์žฅ๊ธฐ์—์„œ ๋ฐœ์ƒํ•˜๋ฉฐ ์‹ฌํ•œ ๊ดด์‚ฌ์™€ ํ˜ˆ๊ด€์†์ƒ์„ ํŠน์ง•์œผ๋กœ ํ•œ๋‹ค. ์•”ํ™” ๊ณผ์ •์—์„œ ๊ด€์—ฌํ•˜๋Š” ๋ช‡๋ช‡ ์œ ์ „์ž ๋ณ€ํ™”๊ฐ€ ๋ณด๊ณ ๋˜๊ณ  ์žˆ์œผ๋‚˜ ๊ทธ ์กฐ์ ˆ๊ธฐ์ „์— ๋Œ€ํ•ด ์•Œ๋ ค์ง„ ๋ฐ”๋Š” ์ ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๋‹ค๋ฅธ ์—ก์Šคํƒ€์ธ ๋ฐ” ๋ฐ”์ด๋Ÿฌ์Šค ๊ด€๋ จ ์•…์„ฑ์ข…์–‘๊ณผ ๋งˆ์ฐฌ๊ฐ€์ง€๋กœ ์ข…์–‘์„ธํฌ์—์„œ ์—ฌ๋Ÿฌ ์œ ์ „์ž๋“ค์˜ ๋ฉ”ํ‹ธํ™”๊ฐ€ ๋น„๊ต์  ๋นˆ๋ฒˆํ•˜๊ฒŒ ๊ด€์ฐฐ๋˜์–ด ๋ฐœ์•”๊ธฐ์ „์˜ ํ•˜๋‚˜๋กœ ์—ฌ๊ฒจ์ง€๊ณ  ์žˆ๋‹ค. microRNA (miRNA)๋Š” 19- ์—์„œ 25- ๋‰ดํด๋ ˆ์˜คํƒ€์ด๋“œ ํฌ๊ธฐ์˜ ๋‹จ๋ฐฑ์งˆ์„ ์ฝ”๋”ฉํ•˜์ง€ ์•Š๋Š” ์ž‘์€ ํฌ๊ธฐ์˜ RNA๋กœ ํ‘œ์  ์œ ์ „์ž์˜ ๋ฐœํ˜„์„ ์Œ์กฐ์ ˆํ•˜๋Š” ์—ญํ• ์„ ํ•œ๋‹ค. ์ตœ๊ทผ miRNA์˜ ๋ฐœํ˜„์ด์ƒ์ด ์ข…์–‘์˜ ๋ณ‘ํƒœ์ƒ๋ฆฌ์™€ ๊ด€๋ จ๋˜์–ด ์žˆ์Œ์ด ๋ฐํ˜€์กŒ๊ณ  ๋ช‡๋ช‡ miRNA๋“ค์€ ์ข…์–‘์ด‰์ง„์œ ์ „์ž ํ˜น์€ ์ข…์–‘์–ต์ œ์œ ์ „์ž๋กœ์„œ์˜ ๊ธฐ๋Šฅ์„ ํ•œ๋‹ค๋Š” ๊ฒฐ๊ณผ๋“ค์ด ๋ณด๊ณ ๋˜์—ˆ๋‹ค. miRNA์˜ ๋ฐœํ˜„์ด์ƒ์€ ํ•ด๋‹น์œ ์ „์ž์˜ ์†Œ์‹ค์ด๋‚˜ ๋ณ€์ด ๋“ฑ ์œ ์ „์ž์ ์ธ ๋ณ€ํ™”๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ํ”„๋กœ๋ชจํ„ฐ CpG ๋ถ€์œ„์˜ ๋ฉ”ํ‹ธํ™”์— ์˜ํ•œ ํ›„์ƒ์œ ์ „์ ์ธ ๋ณ€ํ™”์— ์˜ํ•ด์„œ๋„ ๊ธฐ์ธํ•จ์ด ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ๋”ฐ๋ผ์„œ, ์ €์ž๋“ค์€ ์—ก์Šคํƒ€์ธ ๋ฐ” ๋ฐ”์ด๋Ÿฌ์Šค์™€ ์—ฐ๊ด€๋œ ๋Œ€ํ‘œ์ ์ธ ์•…์„ฑ ์ข…์–‘์ธ NK/T ์„ธํฌ ๋ฆผํ”„์ข…์—์„œ DNA ๋ฉ”ํ‹ธํ™”์— ์˜ํ•ด ๋ฐœํ˜„์ด ์ด์ƒ ์–ต์ œ๋˜์–ด ์žˆ๋Š” miRNA ๋“ค์„ ์ฐพ๊ณ  ์ด๋“ค์˜ ๊ธฐ๋Šฅ๊ณผ ์กฐ์ ˆ๊ธฐ์ „์„ ํ™•์ธํ•˜์—ฌ ์ƒˆ๋กœ์šด ์ข…์–‘์–ต์ œ miRNA๋ฅผ ์ œ์‹œํ•˜์—ฌ NKTL์˜ ๋ฐœ์•”๊ธฐ์ „์— ๋Œ€ํ•œ ์ดํ•ด๋ฅผ ๋†’์ด๊ณ  ์ƒˆ๋กœ์šด ํ‘œ์  ์น˜๋ฃŒ ๋ฌผ์งˆ์„ ์ œ์‹œํ•˜๊ณ ์ž ํ•˜์˜€๋‹ค. NK ์„ธํฌ ๋ฆผํ”„์ข…/๋ฐฑํ˜ˆ๋ณ‘ ์„ธํฌ์ฃผ์—์„œ ํƒˆ๋ฉ”ํ‹ธํ™” ์‹œ์•ฝ ์ฒ˜๋ฆฌ ์‹œ ๋ฐœํ˜„์ด ์ฆ๊ฐ€๋˜๋Š” miRNA๋“ค์„ microarray ๋ถ„์„๊ณผ ์ •๋Ÿ‰์  ์—ญ์ „์‚ฌ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ•์„ ํ†ตํ•ด ์Šคํฌ๋ฆฌ๋‹ํ•˜์˜€๋‹ค. NKTL ์„ธํฌ์ฃผ์˜ ์ƒ์กด๋Šฅ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ miRNA๋“ค์˜ ์œ ์‚ฌ์ฒด๋ฅผ ํŠธ๋ Œ์ŠคํŽ™์…˜ํ•˜์—ฌ CCK8 ์ธก์ •๋ฒ•์„ ์ˆ˜ํ–‰ํ•˜์˜€๋‹ค. ์ƒ์กด๋Šฅ์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒƒ์œผ๋กœ ํŒ๋‹จ๋˜๋Š” miRNA๋“ค์˜ ํ‘œ์ ์œ ์ „์ž๋ฅผ in silico ๋ถ„์„์„ ํ†ตํ•˜์—ฌ ์˜ˆ์ธกํ•˜๊ณ  ์ด ์ค‘ NKTL์˜ ์œ ์ „์ž ๋ณ€ํ™”์™€ ๊ด€๋ จ์žˆ๋Š” miRNA ๋“ค์„ ์„ ์ •ํ•˜์˜€๋‹ค. ์„ ์ •ํ•œ miRNA๋“ค์ด ์‹ค์ œ๋กœ NKTL์˜ ์„ธํฌ์˜ mRNA ๋ฐœํ˜„์„ ์กฐ์ ˆํ•˜๋Š”์ง€ ์—ฌ๋ถ€ ํ™•์ธ์„ ์œ„ํ•ด ์ •๋Ÿ‰์  ๋ฐ ๋ฐ˜์ •๋Ÿ‰์  ์—ญ์ „์‚ฌ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ•์„ ์ˆ˜ํ–‰ํ•˜์—ฌ ํ‰๊ฐ€ํ•˜๊ณ  ๋‹จ๋ฐฑ์งˆ ๋ฐœํ˜„์˜ ์กฐ์ ˆ ์—ฌ๋ถ€ ํ‰๊ฐ€๋ฅผ ์œ„ํ•˜์—ฌ ์›จ์Šคํ„ด ๋ธ”๋กฏ๋ฒ•์„ ์ˆ˜ํ–‰ํ•˜์˜€๋‹ค. SNK6 ์„ธํฌ์ฃผ์—์„œ ํƒˆ๋ฉ”ํ‹ธํ™” ์‹œ microarray๋กœ ์กฐ์‚ฌํ•œ ์ด 888๊ฐœ์˜ miRNA ์ค‘ 77๊ฐœ๊ฐ€ 1.3๋ฐฐ ์ด์ƒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ •๋Ÿ‰์  ํ™•์ธ์„ ์œ„ํ•œ ์ •๋Ÿ‰์  ์—ญ์ „์‚ฌ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ• ๊ฒฐ๊ณผ, ์ด 8๊ฐœ์˜ miRNA๋“ค์ด ํƒˆ๋ฉ”ํ‹ธํ™” ์‹œ ๋‘ ๋ฐฐ (2^(-ฮ”ฮ”Ct)) ์ด์ƒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์„ธํฌ ์ƒ์กด๋Šฅ ํ‰๊ฐ€๋ฅผ ์œ„ํ•œ CCK8 ๋ถ„์„์—์„œ miR-1275, miR-134, miR-20b, miR-376a, miR-654-3p, miR-143, miR-181c, miR-379๊ฐ€ NKTL์˜ ์ƒ์กด๋Šฅ์— ์˜ํ–ฅ์„ ๋ฏธ์น  ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์Œ์„ ํ™•์ธํ•˜์˜€๋‹ค. NKTL์˜ ์•”ํ™”๊ณผ์ •์—์„œ ์ฃผ์š”ํ•œ ๊ฒฝ๋กœ๋กœ ์ž‘์šฉํ•  ๊ฒƒ์œผ๋กœ ํŒ๋‹จ๋˜๋Š” PDGFRฮฑ ๊ฒฝ๋กœ์™€ ๊ทธ ํ•˜์œ„ ๊ฒฝ๋กœ์ธ AKT ๊ฒฝ๋กœ, JAK-STAT ๊ฒฝ๋กœ, ๊ทธ๋ฆฌ๊ณ  p53 ์ด์ƒ, MYC ์œ ์ „์ž์˜ ํ™œ์„ฑํ™”, NFฮบB ๊ฒฝ๋กœ์— ์†ํ•œ ์œ ์ „์ž๋“ค๊ณผ ์ฃผ์š” ์•”ํ™”๊ฒฝ๋กœ ์ค‘ ํ•˜๋‚˜์ธ kRAS ๊ฒฝ๋กœ์— ํ•ด๋‹นํ•˜๋Š” ์œ ์ „์ž๋“ค์„ ํ‘œ์ ์œผ๋กœ ํ•˜๋Š” miRNA๋“ค์„ ์„ ์ •ํ•˜๊ณ  ๊ฐ๊ฐ์˜ ํ‘œ์ ์œ ์ „์ž๋“ค์„ ์›น๊ธฐ๋ฐ˜์˜ ๋ฐ์ดํ„ฐ๋ฒ ์ด์Šค๋ฅผ ํ†ตํ•ด ์˜ˆ์ธกํ•˜์˜€๋‹ค. ๊ทธ ๊ฒฐ๊ณผ miR-20b, miR-143, miR-181c๋ฅผ ์ตœ์ข… ํ›„๋ณด miRNA๋กœ ์„ ์ •ํ•˜์˜€๋‹ค. ์ •๋Ÿ‰์  ์—ญ์ „์‚ฌ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ•์œผ๋กœ ํ™•์ธํ–ˆ์„ ๋•Œ, miR-20b๋Š” ์˜ˆ์ƒ ํ‘œ์  ์œ ์ „๋ฌผ์งˆ์ธ PDGFRฮฑmRNA, STAT3 mRNA, AKT3 mRNA, miR-143์€ PDGFRฮฑ mRNA, miR-181c๋Š” kRAS mRNA ๋ฐœํ˜„์„ ์–ต์ œํ•˜์˜€๋‹ค. ์—ฌ๋Ÿฌ ๋ฐ์ดํ„ฐ๋ฒ ์ด์Šค์—์„œ ๊ณตํ†ต์ ์œผ๋กœ miR-143๊ณผ miR-181c๋Š” kRAS๋ฅผ ํ‘œ์  mRNA๋กœ ์˜ˆ์ธกํ•˜๊ณ  ์žˆ์—ˆ์œผ๋‚˜ ์ •๋Ÿ‰์  ์—ญ์ „์‚ฌ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ•๊ณผ ์›จ์Šคํ„ด ๋ธ”๋กฏ๋ฒ•์œผ๋กœ ํ™•์ธํ•œ ๊ฒฐ๊ณผ, SNK6 ์„ธํฌ์ฃผ์—์„œ๋Š” miR-181c๋งŒ kRAS ํŠน์ด์ ์œผ๋กœ mRNA๋ฅผ ์–ต์ œ์‹œํ‚ฌ ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ (P = 0.013) ๋‹จ๋ฐฑ์งˆ ๋ฐœํ˜„๋„ ์–ต์ œํ•˜์˜€๋‹ค. ๋ฐ˜๋ฉด์— miR-143์€ kRAS mRNA์™€ ๋‹จ๋ฐฑ์งˆ์˜ ๋ฐœํ˜„ ์ •๋„์— ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š์•˜๋‹ค. kRAS๊ฒฝ๋กœ๋Š” ๋งŽ์€ ์•”์ข…์—์„œ ์ฃผ์š” ์•”ํ™”๊ฒฝ๋กœ ์ž„์—๋„ NKTL์—์„œ๋Š” ์œ ์ „์ž์˜ ๋Œ์—ฐ๋ณ€์ด ๋นˆ๋„ ์ •๋„๋งŒ ๋ณด๊ณ ๋˜์–ด ์žˆ์–ด ์‹ค์ œ๋กœ kRAS ๊ฒฝ๋กœ๊ฐ€ NKTL์˜ ์ƒ์žฅ์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š”์ง€ ์—ฌ๋ถ€๋ฅผ ๋จผ์ € ํ™•์ธํ•˜์˜€๋‹ค. RAS์˜ ํ™œ์„ฑ ์–ต์ œ์ œ์ธ salirasib์„ SNK6 ์„ธํฌ์ฃผ์— ์ฒ˜๋ฆฌํ•˜๊ณ  CCK8 ๋ถ„์„์„ ํ•œ ๊ฒฐ๊ณผ ๋†๋„์™€ ์ฒ˜๋ฆฌ ํ›„ ๊ฒฝ๊ณผ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ์„ธํฌ ์ƒ์กด๋Šฅ์ด ๊ฐ์†Œํ•จ์„ ๋ฐœ๊ฒฌํ•˜์˜€๊ณ  ์ด๋Š” kRAS ๊ฒฝ๋กœ๊ฐ€ NKTL์—์„œ ์•”ํ™”๊ฒฝ๋กœ์˜ ํ•˜๋‚˜๋กœ ์ž‘์šฉํ•  ๊ฐ€๋Šฅ์„ฑ์„ ์‹œ์‚ฌํ–ˆ๋‹ค. DNA์˜ ํƒˆ๋ฉ”ํ‹ธํ™”๊ฐ€ ํ›„๋ณด miRNA์˜ ๋ฐœํ˜„์„ ์ฆ๊ฐ€ ์‹œํ‚ด์— ๋”ฐ๋ผ ์ด์˜ ํ‘œ์  ๋ฌผ์งˆ์ธ kRAS๊ฐ€ ๊ฐ์†Œ๋˜์–ด ์กฐ์ ˆ๊ฒฝ๋กœ๊ฐ€ ์–ต์ œ๋  ๊ฒƒ์ด๋ผ๋Š” ๊ฐ€์ • ํ•˜์— ํƒˆ๋ฉ”ํ‹ธํ™” ์‹œ์•ฝ์ธ 5-AzadC๋ฅผ ์ฒ˜๋ฆฌํ•˜์˜€๊ณ  ๊ทธ ๊ฒฐ๊ณผ kRAS์™€ ERK1/2, STAT3 ๋‹จ๋ฐฑ์งˆ์˜ ์–‘๊ณผ ํ™œ์„ฑ์ด ๊ฐ์†Œํ•˜์˜€๋‹ค. ํ•œํŽธ, miR-181c์˜ ์œ ์‚ฌ์ฒด๋ฅผ ์„ธํฌ์ฃผ์— ํŠธ๋ Œ์ŠคํŽ™์…˜ ํ–ˆ์„ ๋•Œ, kRAS ๋‹จ๋ฐฑ์งˆ์˜ ์ด๋Ÿ‰๋ฟ ์•„๋‹ˆ๋ผ kRAS ๊ฒฝ๋กœ๋ฅผ ํ†ตํ•ด ์ธ์‚ฐํ™”๊ฐ€ ์กฐ์ ˆ๋˜๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ง„ STAT3์˜ serine 727 ๋ถ€์œ„์˜ ์ธ์‚ฐํ™”๊ฐ€ ์–ต์ œ๋˜๊ณ  STAT3์˜ ํ™œ์„ฑ์— ์˜ํ•ด ์กฐ์ ˆ๋˜๋Š” ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ง„ VEGF mRNA์˜ ๋ฐœํ˜„์ด ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ๋ฐ˜๋ฉด salirasib์„ ์ฒ˜๋ฆฌํ•œ ๊ฒฝ์šฐ์—๋Š” kRAS ๋‹จ๋ฐฑ์งˆ ์–‘์˜ ๋ณ€ํ™” ์—†์ด STAT3์˜ ํ™œ์„ฑํ™”๋งŒ ๊ฐ์†Œ๋˜์–ด miR-181c๊ฐ€ kRAS mRNA์˜ ๋ฐœํ˜„์„ ์–ต์ œํ•˜์—ฌ kRAS ๋‹จ๋ฐฑ์งˆ์˜ ์ƒ์„ฑ์„ ์–ต์ œํ•˜๊ณ  ๊ทธ ํ•˜์œ„ ์‹ ํ˜ธ์ „๋‹ฌ ๊ฒฝ๋กœ๋ฅผ ์–ต์ œํ•จ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ, SNK6 ์„ธํฌ์ฃผ์— miR-181c ์œ ์‚ฌ์ฒด๋ฅผ ์ฒ˜๋ฆฌํ•˜๋ฉด ์„ธํฌ ์ƒ์กด๋Šฅ์ด ๊ฐ์†Œํ•˜์˜€์œผ๋‚˜ (P = 0.023) kRAS๋ฅผ ๊ณผ๋ฐœํ˜„ ์‹œํ‚ค๋ฉด ์„ธํฌ ์ƒ์กด๋Šฅ์ด ๋‹ค์‹œ ํšŒ๋ณต๋˜์—ˆ์œผ๋ฉฐ (P = 0.012) ์ด๋ฅผ ํ†ตํ•ด miR-181c๊ฐ€ kRAS๋ฅผ ์–ต์ œํ•จ์„ ํ•œ ๋ฒˆ ๋” ํ™•์ธํ•˜์˜€๋‹ค. NKTL์˜ ํฌ๋ฅด๋ง๋ฆฐ๊ณ ์ •-ํŒŒ๋ผํ•€๋ด‰์ž… ๋ธ”๋ก ์กฐ์ง์—์„œ mir-143(P = 0.001), mir-181c (P < 0.0001), mir-20b (P < 0.0001), mir-379 (P < 0.0001)์˜ ๋ฐœํ˜„ ์–‘์ด ๋Œ€ํ‘œ์ ์ธ ์•”ํ™” ์œ ์ „์ž์ธ mir-21์— ๋น„ํ•˜์—ฌ ์ƒ๋Œ€์ ์œผ๋กœ ๋งค์šฐ ์ €ํ•˜๋˜์–ด ์žˆ์Œ์„ ํ™•์ธํ•˜์˜€๊ณ  ํ†ต๊ณ„์  ์œ ์˜์„ฑ์€ ์—†์—ˆ์ง€๋งŒ(P = 0.091) miR-181c์™€ kRAS mRNA ๊ฐ„์— ์Œ์˜ ์ƒ๊ด€๊ด€๊ณ„์˜ ๊ฒฝํ–ฅ์„ฑ์„ ๊ด€์ฐฐํ•˜์˜€๋‹ค(Spearman rank correlation coefficient, ฯ = -0.468). ํ•œํŽธ, ๋ฉ”ํ‹ธํ™”ํŠน์ด์ ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘๋ฒ•์„ ํ†ตํ•ด SNK6 ์„ธํฌ์ฃผ์—์„œ miR-181c์˜ ๋ฉ”ํ‹ธํ™” ๋˜์–ด ์žˆ๋˜ ํ”„๋กœ๋ชจํ„ฐ CpG ๋ถ€์œ„๊ฐ€ 5-AzadC ์ฒ˜๋ฆฌ ํ›„ ํƒˆ๋ฉ”ํ‹ธํ™”๊ฐ€ ์ผ์–ด๋‚˜๋Š” ๊ฒƒ์„ ๋ฐ˜์ •๋Ÿ‰์ ์œผ๋กœ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ ๋ณธ ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด NKTL์—์„œ DNA์˜ ๋ฉ”ํ‹ธํ™”์— ์˜ํ•ด ๋ฐœํ˜„์ด ์–ต์ œ๋˜์–ด ์žˆ์œผ๋ฉฐ ์ข…์–‘์–ต์ œ ๊ธฐ๋Šฅ์„ ํ•  ๊ฒƒ์œผ๋กœ ๊ธฐ๋Œ€๋˜๋Š” miR-20b, miR-143, miR-181c ๋“ฑ ๋ช‡๋ช‡ miRNA๋“ค์„ ์ฐพ์„ ์ˆ˜ ์žˆ์—ˆ์œผ๋ฉฐ ๊ฐ๊ฐ์˜ miRNA๋“ค์ด NKTL์˜ ์•”ํ™”๊ฒฝ๋กœ์—์„œ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•œ๋‹ค๊ณ  ์•Œ๋ ค์ ธ ์žˆ๋˜ ๋ช‡๋ช‡ ํ‘œ์  ์ข…์–‘ ์œ ์ „์ž๋“ค์˜ mRNA์˜ ๋ฐœํ˜„์„ ์–ต์ œํ•จ์„ ํ™•์ธํ•˜์˜€๋‹ค. ํŠนํžˆ, miR-181c๋Š” kRAS ๋‹จ๋ฐฑ์งˆ์˜ ๋ฐœํ˜„์„ ์–ต์ œํ•˜์—ฌ kRAS-STAT3 ์‹ ํ˜ธ์ „๋‹ฌ๊ฒฝ๋กœ๋ฅผ ์ฐจ๋‹จํ•˜๊ณ  ๊ฒฐ๊ณผ์ ์œผ๋กœ VEGF mRNA์˜ ๋ฐœํ˜„์„ ์–ต์ œํ•จ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋”ฐ๋ผ์„œ, ๋ณธ ์—ฐ๊ตฌ๋Š” NKTL์—์„œ ํ›„์ƒ์œ ์ „ํ•™์ ์œผ๋กœ ๋ฐœํ˜„์ด ์–ต์ œ๋˜์–ด ์žˆ๋Š” ์ƒˆ๋กœ์šด ํ›„๋ณด ์ข…์–‘์–ต์ œ์œ ์ „์ž๋ฅผ ์„ ๋ณ„ํ•˜์˜€๊ณ  ์ด๋“ค ์ค‘ ํŠนํžˆ miR-181c์˜ ๊ธฐ๋Šฅ๊ณผ ์กฐ์ ˆ ๊ฒฝ๋กœ๋ฅผ ํ™•์ธํ–ˆ๋‹ค๋Š” ์ ์—์„œ ์˜์˜๊ฐ€ ์žˆ๋‹ค๊ณ  ํ•˜๊ฒ ๋‹ค.Docto

    ์œ ์ „์ž ๋ฐฑ์‹ ์„ ์ด์šฉํ•œ ๊ฒฐํ•ต ๋ฐ ์•” ๋ฉด์—ญ์น˜๋ฃŒ์˜ ํšจ๋Šฅ ์ฆ์ง„์„ ์œ„ํ•œ ์ƒˆ๋กœ์šด ์ „๋žต์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    Thesis(doctoral)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ œ์•ฝํ•™๊ณผ ๋ฏธ์ƒ๋ฌผ์•ฝํ’ˆํ™”ํ•™์ „๊ณต,2005.Docto

    Immunogenicity and efficacy of tuberculosis DNA vaccine encoding Mycobacterium tuberculosis Ag85B by co-immunization with DNA plasmid expressing GM-CSF or IL-18

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์•ฝํ•™๊ณผ ๋ฏธ์ƒ๋ฌผ์•ฝํ’ˆํ™”ํ•™์ „๊ณต,2001.Maste

    ๊ฐ€์šฐ์‹œ์•ˆ ๊ณก์„  ๊ทผ์‚ฌ์— ๊ธฐ๋ฐ˜ํ•œ ์‹ ๊ฒฝ ์‹ ํ˜ธ์˜ ์••์ถ•

    No full text
    Thesis(masters) --์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์ „๊ธฐ. ์ปดํ“จํ„ฐ๊ณตํ•™๋ถ€,2010.2.Maste

    ์น˜์ˆ˜ ๋ฐ ์น˜๊ทผ๋‹จ๋ณ‘์†Œ์—์„œ interleukin-lฮฑ, interleukin-1ฮฒ, tumor necrosis factor-ฮฑ์˜ ๋ถ„ํฌ์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์น˜์˜ํ•™๊ณผ ์น˜๊ณผ๋ณด์กดํ•™์ „๊ณต,1998.Maste

    A STUDY OF HISTOMORPHOLOGICAL CHANGE OF CURVED ROOT CANAL PREPARATION USING GT ROTARY FILE, PROFILE AND STAINLESS STEEL K-FILE

    No full text
    The purpose of this study was to compare the histomorphological change of curved root canal preparation using GT rotary File, Profile .04 taper and stainless steel K-file. 45 mesial canals(over 20 degree) of extracted human mandibular first molars were mounted in resin using a modified Bramante muffle system and divided into three groups. The roots were cross-sectioned at 2.5mm 5mm and 8mm levels from apical foramen. Tracings of the canals were made from preinstrumentation pictures of the cross section. The canals were prepared using a step-back technique with stainless steel K file(group 1), Profile .04 taper rotary file(group 2) and GT rotary file(group 3). Tracings of the prepared canals were made from postinstrumentation picture. Canal centring ratio. amount of transportation, area of dentin removed and shape of canal were measured and statistically were evaluated with Student-Newman-Keuls test using Sigma Stat(Jandel Scientific Software, USA). The results were as followings : 1 Amount of transportation of group 2 was the lowest at apical part, but there was no statistical difference. The direction of transportation was the outside of curvature at apical part. 2. Centering ratio at the apical part of group 1 was the highest, and there was statistical differences between apical and middle part, apical and coronal part(p๏ผœ0.05). Centering ratio at the middle part of group 3 was the lowest, and there was statistical difference between apical and middle part(p๏ผœ0.05). Centering ratio of group 2 was the lowest at apical part, but there was no statistical difference. 3. Amount of dentin removed of group 1 was the highest at coronal, middle and apical part among three groups, and there was statistical difference(p๏ผœ0.05). 4. The majority of the cross-sectioned canal shape after instrumentation were irregular at coronal, middle and apical part. But there are more number of round shaped canals at group 3 than other group.์„œ์šธ๋Œ€ํ•™๊ต ์น˜๊ณผ๋Œ€ํ•™ ๊ธฐ๊ธˆ๊ต์ˆ˜ ํ•™์ˆ ์—ฐ๊ตฌ

    AN ANTI- VIRAL COMPOSITION CONTAINING SESQUITERPENE COMPOUND ISOLATED FROM IXERIS DENTATA

    No full text
    ๋ณธ ๋ฐœ๋ช…์€ ์”€๋ฐ”๊ท€ ์œ ๋ž˜ ์„ธ์Šคํ€ดํ…Œ๋ฅดํŽœ๊ณ„ ํ™”ํ•ฉ๋ฌผ์„ ์œ ํšจ์„ฑ๋ถ„์œผ๋กœ ํฌํ•จํ•˜๋Š” ํ•ญ๋ฐ”์ด๋Ÿฌ์Šค์šฉ ์กฐ์„ฑ๋ฌผ์„ ์ œ๊ณตํ•œ๋‹ค
    corecore